To validate the findings from network pharmacology, molecular docking was employed to estimate the affinity between quercetin and five core targets (MMP1, CXCL8, MMP3, SPP1 and COL1A1) involved in TC-diabetes treatment, separately. This evidence concerns the gene CXCL8 and diabetes mellitus.